MedTrace Logo

A Study to Evaluate the Effect of a Study Product on Quality of Life and Mood

NCT02865863 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2019-02-27

No results posted yet for this study

Summary

A phase II randomized, placebo controlled study evaluating the efficacy of Eurycomalongifoliawater extract (Physta®)+Multivitamin on quality of life and mood on 86 healthy adults over a 24 week supplementation period.

Conditions

  • Quality of Life
  • Mood

Interventions

DIETARY_SUPPLEMENT

Eurycomalongifoliawater extract (Physta®)

DIETARY_SUPPLEMENT

Placebo

DIETARY_SUPPLEMENT

Multivitamin

Sponsors & Collaborators

  • Biotropics Malaysia Berhad

    collaborator INDUSTRY

  • KGK Science Inc.

    lead INDUSTRY

Principal Investigators

  • TengkuShahrirTengku Adnan · Biotropics Malaysia Berhad

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02865863 on ClinicalTrials.gov